BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7686308)

  • 1. Serologic and molecular studies of two kindreds expressing recombinant HLA DR1/DR2 haplotypes.
    Wisecarver J; Shepherd S; Beisel K; Rubocki R
    Tissue Antigens; 1993 Mar; 41(3):148-54. PubMed ID: 7686308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of a recombinant HLA-DR1/DR2 haplotype.
    Bidwell JL; Bidwell EA; Dupont E; Andrien M; Bouillenne C; Klouda PT; Bradley BA
    Hum Immunol; 1992 Apr; 33(4):289-93. PubMed ID: 1353488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
    Sanjeevi CB; Lybrand TP; Landin-Olsson M; Kockum I; Dahlquist G; Hagopian WA; Palmer JP; Lernmark A
    Tissue Antigens; 1994 Aug; 44(2):110-9. PubMed ID: 7817375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial diversity in DR2 haplotypes.
    Wade JA; Hurley CK; Hastings A; Ehrenberg P; Johnson AH; Martell RW; du Toit ED
    Tissue Antigens; 1993 Mar; 41(3):113-8. PubMed ID: 8316942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing complexity of HLA-DR2 as detected by serology and oligonucleotide typing.
    Schreuder GM; van den Berg-Loonen PM; Verduyn W; Geraets DP; Parlevliet J; van Rood JJ; Giphart MJ
    Hum Immunol; 1991 Oct; 32(2):141-9. PubMed ID: 1683866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DR2 haplotypic diversity in populations of South-East Asia, northern China, Melanesia and Australian aborigines using PCR-RFLP for DRB1, DRB5, DQA1 and DQB1. A novel DRB1 allele: DRB1*16022.
    Trejaut J; Bhatia K; Greville WD; Hu KR; Duraisamy G; Nuchprayoon C; Donald J; Aziz A; Dunckley H
    Eur J Immunogenet; 1996 Dec; 23(6):437-49. PubMed ID: 8971541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent HLA DR triplet due to the coexpression of a DRB5-encoded molecule on a DR1 haplotype.
    Gebuhrer L; Tiercy JM; Freidel AC; Labonne MP; Lambert J; Jeannet M; Betuel H
    Hum Immunol; 1992 Jun; 34(2):91-8. PubMed ID: 1429037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel HLA haplotype containing a DRB5 gene associated with the DRB1*0103 allele.
    Perrier P; Leotard B; Henry MA
    Tissue Antigens; 1993 Nov; 42(5):518-21. PubMed ID: 7908467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DR2-associated DRB1 and DRB5 alleles and haplotypes in Koreans.
    Song EY; Kang SJ; Lee YJ; Park MH
    Hum Immunol; 2000 Sep; 61(9):937-41. PubMed ID: 11053638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel HLA-haplotype containing a DRB5 gene not associated with DRB1*15 or DRB1*16 alleles.
    Tautz C; Marsh DG; Baur X
    Tissue Antigens; 1992 Feb; 39(2):91-4. PubMed ID: 1574803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligonucleotide typing analysis for the linkage disequilibrium between the polymorphic DRB1 and DRB5 loci in DR2 haplotypes.
    Tiercy JM; Jeannet M; Mach B
    Tissue Antigens; 1991 Apr; 37(4):161-4. PubMed ID: 1926124
    [No Abstract]   [Full Text] [Related]  

  • 12. Polymorphism and distribution of HLA-DR2 alleles and haplotypes in a Greek population.
    Constantinidou N; Chaidaroglou A; Van den Berg-Loonen EM; Koniavitou K
    Tissue Antigens; 1998 Aug; 52(2):153-7. PubMed ID: 9756404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity in HLA-DR2-related DR,DQ haplotypes in eight populations of Asia-Oceania.
    Gao XJ; Serjeantson SW
    Immunogenetics; 1991; 34(6):401-8. PubMed ID: 1748488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HLA-DRB6*0201 allele of a pseudogene commonly associated with HLA-DR2 specificities is present in an HLA-DRB1*0101-DRB5*0101 haplotype.
    Fischer GF; Fae I; Pickl WF
    Immunogenetics; 1993; 37(4):285-7. PubMed ID: 8093608
    [No Abstract]   [Full Text] [Related]  

  • 15. A family with an apparent HLA-DR triplet: evidence for exchange of functional HLA-DR beta-genes between different haplotypes.
    Tilanus MG; van Eggermond MC; Fei HM; Schreuder GM; Giphart MJ
    Exp Clin Immunogenet; 1989; 6(2):162-8. PubMed ID: 2576521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Dai minority population of southwest China: heterogeneity of DR2-associated HLA-DRB1,DRB5,DQA1, and DQB1 haplotypes.
    Fan L; Chandanayingyong D; Smith AG; Hansen JA
    Hum Immunol; 1996 Feb; 45(2):143-7. PubMed ID: 8882413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of HLA-DR2-associated DRB1 gene in a family.
    Singal DP; Ye M; Joseph S
    Tissue Antigens; 1997 Jul; 50(1):85-8. PubMed ID: 9243764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA typing for class II HLA antigens with allele-specific or group-specific amplification. IV. Typing for alleles of the HLA-DR2 group.
    Moraes ME; Fernandez-ViƱa M; Stastny P
    Hum Immunol; 1991 Jun; 31(2):139-44. PubMed ID: 2066273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with novel HLA-DQB1 allele and unusual DR2 and DR1 haplotypes.
    Erlich HA; Griffith RL; Bugawan TL; Ziegler R; Alper C; Eisenbarth G
    Diabetes; 1991 Apr; 40(4):478-81. PubMed ID: 2010048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-locus analysis of HLA class II genes in DR2-positive IDDM haplotypes in Finland. The "Childhood Diabetes in Finland" (DiMe) Study Group.
    Reijonen H; Ilonen J; Akerblom HK; Knip M; Dosch HM
    Tissue Antigens; 1994 Jan; 43(1):1-6. PubMed ID: 7912856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.